Nowo Cobertura [new] Jun 2026

As Novo Nordisk resolves manufacturing bottlenecks, supply constraints will ease. This will likely shift the conversation from "We can't give you the drug because it's out of stock" to "We won't pay for the drug because of policy," sharpening the focus on insurance reform.